Establishment of a Monoclonal Antibody-Based Enzyme-Linked Immunosorbent Assay to Measure Soluble B7-H5 in Patients with Cancer

Table 1

The relationship between the levels of sB7-H5 in sera of patients with GC and clinicopathological characteristics.

Characteristics		sB7-H5 expression
		Median (Min–Max)	~
Age
<68	24	421.0 (306.9-4512)	357.8-516.4	224.0	0.0890
≥68	26	388.2 (156.2-911.1)	265.4-511.0
Gender
Male	37	428.7 (156.2-1018)	331.6-518.9	204.0	0.4230
Female	13	369.5 (159.8-4512)	327.1-436.2
TNM
I+II	14	361.2 (194.6-508.5)	304.2-400.0	155.0	0.0353
III+IV	36	448.0 (156.2-4512)	342.5-527.7
Metastasis
No	13	381.5 (194.6-518.5)	321.4-403.8	165.0	0.0955
Yes	37	442.9 (156.2-4512)	334.2-526.1

TNM: tumor node metastasis. .